Yep, there are a hand full of punters that are excited to see .19c they either can not afford to hold on or they are missing the big picture here, I will get excited when I see them trading at above $10 after they receive the US$1 Billion on offer.
See below Extract from Bioworld announcement 19/04/18
Recce has its eyes on the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) global initiative, which is offering a $1 billion reward for each new antibiotic approved, as well as increased R&D funding. The QIDP designation is making big waves among Australian investors, Graham said.
RCE Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)